Thank you for your interest in the HIV/Hep C Clinical Preceptorship Program.

The STEPS program coordinates opportunities for physicians and nurse practitioners who are currently practicing in Saskatchewan to participate in half or full day clinics to observe an STBBI specialist provide patient care.

Please note: Limited number of opportunities are available and participants are prioritized based on the following criteria:

1) Currently (or interested) in prescribing HIV and/or Hep C medication treatment.
2) Currently (or will) be working in a clinic with a moderate or high volume of patients who require HIV/Hep C/STBBI care.
3) Have received HIV/Hep C/STBBI continuing medical education from the STEPS program.

Question Title

* 1. First name

Question Title

* 2. Last name

Question Title

* 3. Email address

Question Title

* 5. Which organization do you belong to:

Question Title

* 6. Which Saskatchewan community do you reside in?

Question Title

* 7. Which Saskatchewan communities do you practice in? (Ex: Saskatoon)

Question Title

* 8. If applicable, what is the name of the clinic(s) that you currently work at?

Question Title

* 9. Which STBBIs are you interested in observing care of? Select all that apply.

Question Title

* 10. Are you willing to travel to another community for this opportunity? (For example, Prince Albert, Saskatoon, Regina, or North Battleford)

Question Title

* 11. Do you have a preference for a full or half day experience?

Question Title

* 12. Are you currently enrolled onto SK Drug Plan as a:

Question Title

* 13. In the last 12 months, how many people living with each STBBI have you provided care to?

  Zero 1-10 11-20 21-30 31-40 41-50 51-60 60+
HIV
Hep C
Syphilis

Question Title

* 14. Which statement BEST describes your current HIV clinical practice?

Question Title

* 15. Which statement BEST describes your current Hep C clinical practice?

Question Title

* 16. Which statement BEST describes your current syphilis clinical practice?

Question Title

* 17. Why are you interested in participating in a HIV and/or Hep C Clinical Preceptorship?

Question Title

* 18. Additional comments:

T